No Detail Found!

A validated method for the determination of quetiapine fumarate tablets in human plasma by UPLC-MS/MSand its application to a pharmacokinetic study in healthy chinese subjects

Author(s)
Kaiwei Luo Fuan Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd., Ningbo, China
Haiming Zhao Fuan Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd., Ningbo, China
Huina Zhang Fuan Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd., Ningbo, China
Lihong Huang Fuan Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd., Ningbo, China
Jie Lin Fuan Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd., Ningbo, China
Qunan Cheng Fuan Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd., Ningbo, China
Wenjuan Yang Tongde Hospital of Zhejiang Province, Hangzhou, China
Weiyong Lu Tongde Hospital of Zhejiang Province, Hangzhou, China
Pingping Sun Tongde Hospital of Zhejiang Province, Hangzhou, China
Tingting Lou Tongde Hospital of Zhejiang Province, Hangzhou, China
Abstract
A rapid, highly specific and sensitive UPLC-MS/MS method was developed for the determination of Quetiapine Fumarate, a therapeutic drug for various psychiatric disorders, in human plasma. The samples were pretreated using a protein precipitation method, followed by chromatographic separation using a column (Kinetex C18, 2.6 µm 50*2.1 mm) equipped with an ESI source and MRM mode mass spectrometer. In the validation results of the method, the analyte quetiapine showed a peak at approximately 1.0 minute and exhibited good linearity within the concentration from 2.5 to 2000ng/mL. The intra- and inter-batch precision CV% were within the range of -1.3% to 7.7% and precision of intra- and inter-batch were below 15.0%. Furthermore, this method demonstrated low matrix effects and high recovery rates. The quetiapine plasma sample solution remained stable at room temperature for 25 hours and following 4 freezethaw cycles. The prepared samples remained stable in the autosampler (The temperature control of the autosampler was 5oC) for 185 hours and after four freeze-thaw cycles at -20oC and -70oC for 40 days. The present work effectively employed this approach to investigate the pharmacokinetics of orally administered quetiapine fumarate tablets in a cohort of healthy Chinese individuals, both in a fasting state and after a meal.
Publication Details
Page(s) 1597-1607
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 36, Issue: 5-S, Year: 2023

Request the full text from PASTIC

Keywords
Validation, Quetiapine fumarate, UPLC-MS/MS, Pharmacokinetic
0

Citations

0

Downloads

124

Views